DK1492513T3 - HFA-suspensionsformuleringer indeholdende et anticholinergikum - Google Patents

HFA-suspensionsformuleringer indeholdende et anticholinergikum

Info

Publication number
DK1492513T3
DK1492513T3 DK03745193T DK03745193T DK1492513T3 DK 1492513 T3 DK1492513 T3 DK 1492513T3 DK 03745193 T DK03745193 T DK 03745193T DK 03745193 T DK03745193 T DK 03745193T DK 1492513 T3 DK1492513 T3 DK 1492513T3
Authority
DK
Denmark
Prior art keywords
anticholinergic
formulations containing
suspension formulations
hfa suspension
hfa
Prior art date
Application number
DK03745193T
Other languages
Danish (da)
English (en)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1492513(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1492513T3 publication Critical patent/DK1492513T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK03745193T 2002-03-28 2003-03-20 HFA-suspensionsformuleringer indeholdende et anticholinergikum DK1492513T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum

Publications (1)

Publication Number Publication Date
DK1492513T3 true DK1492513T3 (da) 2006-12-18

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03745193T DK1492513T3 (da) 2002-03-28 2003-03-20 HFA-suspensionsformuleringer indeholdende et anticholinergikum

Country Status (26)

Country Link
EP (2) EP1492513B1 (pl)
JP (1) JP4480401B2 (pl)
KR (1) KR101066801B1 (pl)
CN (1) CN1329023C (pl)
AT (1) ATE339953T1 (pl)
AU (1) AU2003209743B2 (pl)
BR (1) BR0308764A (pl)
CA (1) CA2479640C (pl)
CY (1) CY1105543T1 (pl)
DE (2) DE10214263A1 (pl)
DK (1) DK1492513T3 (pl)
EA (1) EA007239B1 (pl)
EC (1) ECSP045321A (pl)
ES (1) ES2273020T3 (pl)
HR (1) HRP20040889B1 (pl)
IL (2) IL163697A0 (pl)
ME (1) ME00247B (pl)
MX (1) MXPA04009337A (pl)
NO (1) NO20044005L (pl)
NZ (1) NZ536043A (pl)
PL (1) PL371296A1 (pl)
PT (1) PT1492513E (pl)
RS (1) RS52178B (pl)
UA (1) UA78557C2 (pl)
WO (1) WO2003082252A1 (pl)
ZA (1) ZA200405638B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101297061B1 (ko) † 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
BR112015006571A2 (pt) * 2012-10-23 2017-07-04 Cipla Ltd composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
WO2002030928A1 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
CA2436540C (en) * 2000-10-31 2008-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
PL371296A1 (pl) 2005-06-13
YU85904A (sh) 2006-08-17
HK1079091A1 (en) 2006-03-31
NO20044005L (no) 2004-10-05
DE50305118D1 (de) 2006-11-02
EA200401190A1 (ru) 2005-04-28
EP1695701B1 (de) 2015-01-07
ME00247B (me) 2011-05-10
MEP47408A (en) 2011-02-10
KR101066801B1 (ko) 2011-09-22
AU2003209743A1 (en) 2003-10-13
UA78557C2 (en) 2007-04-10
ATE339953T1 (de) 2006-10-15
IL163697A0 (en) 2005-12-18
NZ536043A (en) 2005-09-30
IL163697A (en) 2011-03-31
BR0308764A (pt) 2005-01-11
EP1695701A3 (de) 2010-04-28
HRP20040889A2 (en) 2004-12-31
CA2479640C (en) 2010-09-28
EP1695701A2 (de) 2006-08-30
CY1105543T1 (el) 2010-07-28
CN1329023C (zh) 2007-08-01
EA007239B1 (ru) 2006-08-25
JP4480401B2 (ja) 2010-06-16
JP2005529087A (ja) 2005-09-29
KR20040098031A (ko) 2004-11-18
MXPA04009337A (es) 2005-01-25
PT1492513E (pt) 2006-12-29
CN1642534A (zh) 2005-07-20
ECSP045321A (es) 2005-01-28
ES2273020T3 (es) 2007-05-01
ZA200405638B (en) 2005-07-27
HRP20040889B1 (hr) 2012-11-30
AU2003209743B2 (en) 2008-03-06
RS52178B (sr) 2012-10-31
CA2479640A1 (en) 2003-10-09
EP1492513B1 (de) 2006-09-20
DE10214263A1 (de) 2003-10-16
EP1492513A1 (de) 2005-01-05
WO2003082252A1 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
IS7653A (is) MCHIR mótlyf
DE60323810D1 (de) Bequem Windel
ITTO20020667A0 (it) Microvelivolo vtol
DK1670472T3 (da) Aerosolformulering til inhalation indeholdende et antikolinergikum
DE60312863D1 (de) Fahrgestell
DK1572229T3 (da) Stabilt terapeutisk fibrinogen
IS8309A (is) Lyfjablöndur
NO20034824D0 (no) Cepham-forbindelser
DE60236403D1 (de) Tourbillonmechanismus
DK1492513T3 (da) HFA-suspensionsformuleringer indeholdende et anticholinergikum
DE602004022022D1 (de) Dilatationsvorrichtung
NO20023047D0 (no) Kompenseringsanordning
NO20026138L (no) Stabilisator for radiofarmasöytiske midler
ATE535775T1 (de) Präzisionsdendrometer
NO20024880D0 (no) Sammensetning inneholdende fosfat
ITMI20031187A0 (it) Astuccio per occhiali
DE60237924D1 (de) Brillengelenk
EP1430904A4 (en) desensitisers
EP1483237A4 (en) TROPANVERBINDUNGEN
SI1492513T1 (sl) HFA-suspenzijske formulacije, ki vsebujejo antiholinergik
DK1529340T3 (da) Klasse D-forstærker
AU2003299720A8 (en) Optical amplifier
FR2854182B1 (fr) Suspente auto-fixable
ATA6252001A (de) Schreibhilfe
NL300932I2 (nl) ocrelizumab